The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
43 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $23,106,243 in first-year total cost, median $528,041.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BST-F (55)]39
- Special Emphasis Panel[ZRG1-BST-F(55)R]4
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL2
- DUKE UNIVERSITY2
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2
- JOHNS HOPKINS UNIVERSITY2
- KANSAS STATE UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | High-throughput assays and small-molecule discovery of antiviral candidates targeting influenza hemagglutinin1R01AI150885-01A1 | WILSON, IAN A | SCRIPPS RESEARCH INSTITUTE, THE, CA | $678,526 | ZRG1 |
| 2021 | A high-throughput platform to identify selective allosteric inhibitors of the PLC-y isozymes1R01CA258993-01 | PEARCE, KENNETH HUGHSONDEK, JOHN EZHANG, QISHENG | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $569,708 | ZRG1 |
| 2021 | Discovery of small molecules targeting the histone acetylation reader ENL1R01CA255506-01 | WEN, HONG | VAN ANDEL RESEARCH INSTITUTE, MI | $454,068 | ZRG1 |
| 2021 | Identification of novel anthelmintics through a target-based screen of a parasite ion channel1R01AI155405-01 | MARCHANT, JONATHAN SSCAMPAVIA, LOUIS DANIEL | MEDICAL COLLEGE OF WISCONSIN, WI | $373,743 | ZRG1 |
| 2021 | Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis1R01AI156382-01 | CHRISTENSEN, KENNETH AGOLDEN, JENNIFER E.MORRIS, JAMES CULVINWERBOVETZ, KARL A | CLEMSON UNIVERSITY, SC | $223,077 | ZRG1 |
| 2020 | HTS Targeting HIV-1 Protease Autoprocessing for First in Class Drug Discovery1R01AI150223-01 | CHEN, CHAOPINGCHUNG, THOMAS D YSHERMAN, DAVID H | COLORADO STATE UNIVERSITY, CO | $803,950 | ZRG1 |
| 2020 | Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS21R01AI148178-01 | SCHWAB, SUSAN RUTH | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $672,866 | ZRG1 |
| 2020 | High Throughput Screen for Inhibitors of Shigella Flexneri Dissemination1R01AI153455-01 | AGAISSE, HERVE FENGEL, DANIEL A | UNIVERSITY OF VIRGINIA, VA | $627,361 | ZRG1 |
| 2020 | Developing Bacterial Glycosyltransferase Inhibitors as Anti-Virulence Drugs1R56AI153202-01 | HARDWIDGE, PHILIP ROSS | KANSAS STATE UNIVERSITY, KS | $614,542 | ZRG1 |
| 2020 | Automated high throughput compound screening for broadly active anti-parasitic nematode drugs1R01AI150866-01 | AROIAN, RAFFI V | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $602,642 | ZRG1 |
| 2020 | Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A1R01CA250459-01A1 | ARKIN, MICHELLEFUJIMORI, DANICA GALONIC | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $584,086 | ZRG1 |
| 2020 | Targeting epigenetic reader GAS411R01CA240514-01A1 | CIERPICKI, TOMASZ | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $528,041 | ZRG1 |
| 2020 | Identification of small molecule modulators of mitochondrial creatine kinase 11R01CA251910-01 | HITOSUGI, TAROSERGIENKO, EDUARD A. | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $520,361 | ZRG1 |
| 2020 | Inhibiting sequential biosynthetic steps of a fungal-specific organelle1R01AI148235-01A1 | KOEHLER, JULIA RPOLLASTRI, MICHAEL P | BOSTON CHILDREN'S HOSPITAL, MA | $510,459 | ZRG1 |
| 2020 | Targeting the Sam68-stimulated PARP1 activation for cancer treatment1R01CA244350-01A1 | WAN, FENGYI | JOHNS HOPKINS UNIVERSITY, MD | $451,191 | ZRG1 |
| 2020 | Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune System1R01CA233567-01A1 | STIVERS, JAMES T. | JOHNS HOPKINS UNIVERSITY, MD | $374,578 | ZRG1 |
| 2019 | Development of validated probes for the bacterial type III secretion system1R01AI141511-01A1 | STONE, VICTORIA AUERBUCH | UNIVERSITY OF CALIFORNIA SANTA CRUZ, CA | $762,541 | ZRG1 |
| 2019 | High throughput screening of the Prp8 intein splicing inhibitors for pathogenic fungi1R01AI140726-01A1 | LI, HONGMIN | WADSWORTH CENTER, NY | $664,586 | ZRG1 |
| 2019 | Identification of CYP5122A1 inhibitors as chemical probes for Leishmania biology1R01AI139198-01A1 | WANG, ZHUO MICHAEL | UNIVERSITY OF KANSAS LAWRENCE, KS | $648,204 | ZRG1 |
| 2019 | Optimizing the immune response by targeting the Sts enzymes1R01AI141592-01 | CARPINO, NICHOLAS AFRENCH, JARROD BSCAMPAVIA, LOUIS DANIEL | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $630,428 | ZRG1 |
| 2019 | Novel Screening Platform for Discovery of DUB Targeting Probes1R01CA233800-01A1 | BUHRLAGE, SARA JMARTO, JARROD A. | DANA-FARBER CANCER INST, MA | $629,796 | ZRG1 |
| 2019 | High Throughput Screening for Non-antibiotic inhibitors of Clostridium difficile Pathophysiology1R01AI144459-01 | HURDLE, JULIAN G | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $577,822 | ZRG1 |
| 2019 | HTS for TGF-beta receptor assembly inhibitors with anti-tumor and anti-fibrosis activities1R01CA233622-01A1 | HINCK, ANDREW PJOHNSTON, PAUL A. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $572,036 | ZRG1 |
| 2019 | Large-scale screen with a novel assay against RNA editing to identify anti-trypanosomal agents1R01AI143593-01 | SALAVATI, REZA SALAVATI | MCGILL UNIVERSITY, QC | $556,320 | ZRG1 |
| 2019 | Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expression1R01AI141507-01A1 | TUSCHL, THOMAS | ROCKEFELLER UNIVERSITY, NY | $538,003 | ZRG1 |
| 2019 | Assay development and screening for inhibitors targeting Shiga toxin 21R01AI141635-01A1 | LI, XIAO-PING | RUTGERS, THE STATE UNIV OF N.J., NJ | $526,594 | ZRG1 |
| 2019 | Discovery of Hsp100-selective inhibitors for targeting multiple microbial pathogens1R01AI141586-01A1 | ROY, ANURADHASCHOENEN, FRANKZOLKIEWSKI, MICHAL | KANSAS STATE UNIVERSITY, KS | $514,035 | ZRG1 |
| 2019 | Discovery of Gram-negative permeable chemical probes for tRNA methylation1R01AI139202-01A1 | HOU, YA-MING | THOMAS JEFFERSON UNIVERSITY, PA | $495,998 | ZRG1 |
| 2019 | Small molecules to block measles spreading in the central nervous system1R56AI146980-01 | POROTTO, MATTEO | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $492,576 | ZRG1 |
| 2019 | High Throughput Screening of Inhibitors Targeting the Enterovirus A71 and D68 2A Proteases1R01AI147325-01 | WANG, JUN | UNIVERSITY OF ARIZONA, AZ | $481,106 | ZRG1 |
| 2019 | Cell-based high-throughput chemical genetic screening for GSDMD inhibitors1R01AI141386-01 | LUO, HONGBO R | BOSTON CHILDREN'S HOSPITAL, MA | $442,500 | ZRG1 |
| 2019 | Identification of human cytomegalovirus life cycle stage-specific therapeutics1R01AI139258-01A1 | TORTORELLA, DOMENICO | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $413,552 | ZRG1 |
| 2019 | qHTS of Patient Derived HCC Models to Identify Novel Probes/Therapeutic Agents1R01CA229836-01A1 | JOHNSTON, PAUL A. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $400,283 | ZRG1 |
| 2019 | Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens1R01AI139216-01A1 | ZHOU, PEI | DUKE UNIVERSITY, NC | $387,505 | ZRG1 |
| 2019 | Target-specific antimalarial compound identification using phenotypic assays1R01AI141543-01A1 | NILES, JACQUIN C | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $377,417 | ZRG1 |
| 2018 | Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation1R01AI139014-01 | HAECKER, HANS | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $812,562 | ZRG1 |
| 2018 | Discovery and validation of pan-influenza antivirals1R56AI139015-01 | CHANDA, SUMIT KSHAW, MEGAN LOUISE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $749,135 | ZRG1 |
| 2018 | Parallel Multimodal High-throughput screening to identify activators of the orexin receptors1R01MH117499-01 | KAMENECKA, THEODORE MKENNY, PAUL J.SCAMPAVIA, LOUIS DANIEL | SCRIPPS FLORIDA, FL | $598,887 | ZRG1 |
| 2018 | Identification of Chemical Probes for the Orphan Nuclear Receptor NR2F61R01CA225890-01A1 | SCAMPAVIA, LOUIS DANIELSOLT, LAURA A | SCRIPPS FLORIDA, FL | $577,866 | ZRG1 |
| 2018 | A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS1R01CA223495-01A1 | ROSSMAN, KENT | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $454,077 | ZRG1 |
| 2018 | Development of small molecules to target KDM4B1R01CA229739-01 | CHEN, TAOSHENGDAVIDOFF, ANDREW MWHITE, STEPHEN WYANG, JUN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $410,606 | ZRG1 |
| 2018 | Development of neutral ceramidase inhibitor tool compounds1R01CA221948-01A1 | HALEY, JOHN DOUGLASSCAMPAVIA, LOUIS DANIEL | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $409,190 | ZRG1 |
| 2018 | Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens1R56AI139216-01 | ZHOU, PEI | DUKE UNIVERSITY, NC | $393,419 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.